• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles

Comprehensive Analysis of (1S)-1-(1-methylpyrazol-3-yl)ethanol (CAS No. 1568191-60-5): Properties, Applications, and Industry Insights

In the rapidly evolving field of fine chemicals and pharmaceutical intermediates, (1S)-1-(1-methylpyrazol-3-yl)ethanol (CAS No. 1568191-60-5) has garnered significant attention due to its unique structural features and versatile applications. This chiral alcohol derivative, characterized by its 1-methylpyrazole moiety and ethanol backbone, serves as a critical building block in asymmetric synthesis and drug discovery. With the growing demand for enantiomerically pure compounds in medicinal chemistry, this compound's stereoselective synthesis and pharmacophore potential make it a subject of intense research.

The compound's molecular structure (C₆H₁₀N₂O) features a pyrazole ring substituted at the 3-position with a hydroxyethyl group, offering both hydrogen bond donor/acceptor capabilities and lipophilic properties. Such characteristics align with current trends in fragment-based drug design, where researchers prioritize small molecules with high ligand efficiency. Recent publications highlight its utility in developing kinase inhibitors, particularly for oncology targets, addressing the global surge in cancer-related queries and therapeutic innovations.

From a synthetic chemistry perspective, 1568191-60-5 exemplifies the importance of chiral auxiliaries in achieving enantiomeric purity—a topic frequently searched in academic and industrial forums. Its production often involves asymmetric reduction of corresponding ketones using biocatalysts or transition metal complexes, reflecting the industry's shift toward green chemistry principles. Environmental concerns and regulatory pressures have made biocatalytic routes a trending subject, with this compound serving as a case study for sustainable manufacturing.

Analytical characterization of (1S)-1-(1-methylpyrazol-3-yl)ethanol typically employs HPLC chiral separation, NMR spectroscopy, and mass spectrometry—techniques widely discussed in online forums about quality control in pharma. The compound's stability profile under various pH conditions makes it suitable for formulation studies, another hot topic given the rise of oral bioavailability optimization searches. Its logP value (~0.8) suggests balanced hydrophilicity/lipophilicity, crucial for ADME property predictions in early drug development.

Market intelligence reveals growing patent activity around pyrazole derivatives, with 1568191-60-5 appearing in applications ranging from neurodegenerative disease modulators to agricultural chemicals. This aligns with increasing public interest in precision medicine and sustainable agrochemicals. The compound's metabolic stability and toxicity profile are frequently queried parameters, reflecting end-users' needs for comprehensive safety data in compliance with REACH regulations.

In conclusion, (1S)-1-(1-methylpyrazol-3-yl)ethanol represents a compelling case of how specialized intermediates bridge chemical innovation with therapeutic advancement. Its relevance to structure-activity relationship studies and lead optimization processes ensures continued interest from both synthetic chemists and pharmacologists. As AI-driven molecular property prediction tools become mainstream, compounds like this will serve as valuable benchmarks for computational chemistry validation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)